← All stocks

Arcadia Biosciences, Inc.

RKDA Net buying
CIK 0001469443 #5615 in the set updated 22 Sep 2026
Bought (120 mo)
$239.24K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.19M
$0.00 on a plan · $1.19M straight out of an exercise
Sold at will
$1.36K
1 of 5 sales
Net
−$951.22K
+$237.89K against sales at will

By person

11 insiders · 32 transactions
0.0×

Thomas J. Schaefer holds only 0.0 times base salary in stock. $7.02K of shares against $260.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas J. Schaefer last reported holding, valued at $2.49, the price Common Stock was last bought or sold at on the open market here, on 3 Feb 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Rey Eric J.
Director
$3.75K (1)
$1.13M (3) scheduled
−$1.13M
7,335
0.3045%
$18.26K
+214.1%
Comcowich Kevin
Director
$126.72K (3)
+$126.72K
20,000
0.8301%
$49.80K
Lu Zhongjin
VP Product Development
$58.65K (2) scheduled
−$58.65K
558
0.0232%
$1.39K
−91.4%
Plavan Matthew T
Chief Executive Officer
$30.65K (6)
+$30.65K
14,285
0.5929%
$35.57K
Jacot Stanley Jr
Chief Executive Officer
$21.55K (1)
+$21.55K
5,000
0.2075%
$12.45K
Murray Lilian Shackelford
Director
$21.25K (1)
+$21.25K
8,524
0.3538%
$21.22K
+141.9%
Reiter Sarah
Chief Commercial Officer
$18.86K (4)
+$18.86K
3,800
0.1577%
$9.46K
Schaefer Thomas J.
Chief Executive Officer
$7.17K (5)
+$7.17K
2,819
0.1170%
$7.02K
Haley Pamela
Chief Financial Officer
$3.91K (3)
+$3.91K
5,088
0.2112%
$12.67K
+70.3%
Kawakami Mark
Chief Financial Officer
$3.19K (2)
+$3.19K
2,681
0.1113%
$6.68K
+109.3%
Shultz Randall
Chief Technology Officer
$2.21K (1)
+$2.21K
13,000
0.5396%
$32.37K
+5.7%
Insider
Date
Role
Action
Shares
Price
Amount
Schaefer Thomas J.
3 Feb 2025
Chief Executive Officer
Buy
700
$2.49
$1.74K
Kawakami Mark
3 Feb 2025
Chief Financial Officer
Buy
700
$2.49
$1.74K
Schaefer Thomas J.
1 Aug 2024
Chief Executive Officer
Buy
700
$2.06
$1.44K
Kawakami Mark
1 Aug 2024
Chief Financial Officer
Buy
700
$2.06
$1.44K
Schaefer Thomas J.
1 Feb 2024
Chief Financial Officer
Buy
700
$2.06
$1.44K
Schaefer Thomas J.
4 Aug 2023
Chief Financial Officer
Buy
649
$3.67
$2.38K
Jacot Stanley Jr
30 May 2023
Chief Executive Officer
Buy
5,000
$4.31
$21.55K
Schaefer Thomas J.
1 Feb 2023
Chief Financial Officer
Buy
700
$0.23
$161.00
Haley Pamela
1 Aug 2022
Chief Financial Officer
Buy
700
$0.70
$490.00
Haley Pamela
3 Aug 2020
Chief Financial Officer
Buy
700
$3.16
$2.21K
Shultz Randall
3 Aug 2020
Chief Technology Officer
Buy
700
$3.16
$2.21K
Plavan Matthew T
3 Aug 2020
Chief Executive Officer
Buy
585
$3.16
$1.85K
Plavan Matthew T
3 Feb 2020
Chief Executive Officer
Buy
700
$1.72
$1.20K
Reiter Sarah
3 Feb 2020
Chief Commercial Officer
Buy
700
$1.72
$1.20K
Haley Pamela
3 Feb 2020
Chief Financial Officer
Buy
700
$1.72
$1.20K
Reiter Sarah
23 Dec 2019
Chief Commercial Officer
Buy
900
$5.95
$5.36K
Reiter Sarah
19 Nov 2019
Chief Commercial Officer
Buy
1,000
$4.52
$4.52K
Murray Lilian Shackelford
18 Nov 2019
Director
Buy
5,000
$4.25
$21.25K
Plavan Matthew T
14 Nov 2019
Chief Executive Officer
Buy
1,000
$4.08
$4.08K
Plavan Matthew T
23 Sep 2019
Chief Executive Officer
Buy
2,000
$5.25
$10.50K
Comcowich Kevin
17 Sep 2019
Director
Buy
5,000
$5.88
$29.39K
Comcowich Kevin
10 Sep 2019
Director
Buy
10,000
$6.49
$64.90K
Comcowich Kevin
10 Sep 2019
Director
Buy
5,000
$6.49
$32.43K
Reiter Sarah
10 Sep 2019
Chief Commercial Officer
Buy
1,200
$6.48
$7.78K
Plavan Matthew T
10 Sep 2019
Chief Executive Officer
Buy
1,000
$6.52
$6.52K
Plavan Matthew T
10 Sep 2019
Chief Executive Officer
Buy
1,000
$6.49
$6.49K
Rey Eric J.
8 Jun 2017
Director
Buy
5,000
$0.75
$3.75K

What was left out

Form 4 filings counted 112
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 4
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 36,005
Sales filed before the plan box existed 1
History held since 12 Sep 2016